19

Regional Update

  • Upload
    cyndi

  • View
    28

  • Download
    0

Embed Size (px)

DESCRIPTION

Regional Update. Financial Report. Governance Report. Dr. Joel Pachter Progressive MS Update. Leukocytes enter the CNS during neuroinflammation. The blood-brain barrier is damaged during EAE/MS. Urgent Need to Find Solutions for People with Progressive MS. - PowerPoint PPT Presentation

Citation preview

Page 1: Regional Update
Page 2: Regional Update

2

Regional Update

Page 3: Regional Update

3

Financial Report

Page 4: Regional Update

4

Governance Report

Page 5: Regional Update

5

Dr. Joel PachterProgressive MS Update

Page 6: Regional Update

Leukocytes enter the CNS during neuroinflammation

Page 7: Regional Update

The blood-brain barrier is damaged during EAE/MS

Page 8: Regional Update

8

Urgent Need to Find Solutions for People with Progressive MS

•Large worldwide impact: about half of all MS patients

•Finding solutions for progressive MS is one of the top priorities for patients

•Currently paucity of effective DMT for progressive forms of MS

•Every time another therapy is approved for RRMS, a large proportion of our constituents feel left behind

Page 9: Regional Update

9

Society Research Priorities1. To better understand the biological

basis for disease progression

2. To dissect the mechanisms of nerve damage and repair

3. To identify risk and triggering factors for MS

4. To enable development of new or improved rehabilitation techniques

5. To grow the global MS research enterprise

$46 million in current commitments to progressive MS research

Page 10: Regional Update

10

Progressive MS Research Initiatives1. Over 100 investigator initiated research projects

2. MS Outcomes Assessment Consortium

3. Clinical Trials- MS SMART, SPRINT MS

4. SUMMIT natural history and risk factors study

5. Revision of Lublin-Reingold Clinical Course Descriptor

6. International Progressive MS Alliance

Page 11: Regional Update

MissionTo expedite the development of effective disease modifying and symptom management therapies for progressive forms of multiple sclerosis

Page 12: Regional Update
Page 13: Regional Update
Page 14: Regional Update

Better extravasating of hES-MSC

Page 15: Regional Update

Where is MS research going?

Novel drugs that act on “special” targets (e.g., CCL2)

Stem cell therapy with multifunctional “reparative” rather “replacement” cells

Riluzole – sodium channel blockerAmiloride – diuretic/neuroprotectiveIbudilast – anti-inlfammatory/neuroprotective

Page 16: Regional Update

16

• What FDA approved medications can we expect for secondary progressive MS, and when?

• When will oral therapies be available for progressive MS?

• I see your major research interests are blood brain barrier & neuroinflammation. How do you feel about these as treatment options? What do you suggest we look for when searching for a doctor to treat this?

Q&AMedications & Treatments

Page 17: Regional Update

17

• How soon are we going to see expansion of the stem cell clinical trials?

• Are clinical trails for stem cells taking place in the US?

• Will stem cell therapy become available and if so how would this therapy help any type of MS?

Q&AStem Cells

Page 18: Regional Update

18

• What are the prospects for remylination?

• What progress has been made in RESTORING function, especially in patients who've had MS 20 years?

Q&ARestoring Function

Page 19: Regional Update

19

• What is the difference between the different types of MS? My daughter was recently diagnosed.

• As an undergraduate student starting to study MS, where is the best place to start?

• Will there ever be a cure for MS?

• Is it common for Parkinsons Disease and MS to occur in the same person? Is research being done around this?

Q&AGeneral